Compounded medications are not reviewed by the FDA for safety, effectiveness or manufacturing quality in the same manner as FDA-approved drugs
What users commonly report: Continued gradual fat loss, but slower than weeks 6-8 Body composition improvements consolidate Some users plateau around week 10 Decision point: Most protocols recommend stopping at 8-12 weeks with a 4-6 week break before repeating
Some peptides remain stable in saline
Most reactions resolve spontaneously upon continued use or dose adjustment
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Get in touch to learn more about the rankings, the data behind them, and how your sportsbook compares with the market